0001235802-11-000185.txt : 20111115 0001235802-11-000185.hdr.sgml : 20111115 20111115111550 ACCESSION NUMBER: 0001235802-11-000185 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111114 FILED AS OF DATE: 20111115 DATE AS OF CHANGE: 20111115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROSENOW EDWARD C III CENTRAL INDEX KEY: 0001241294 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31812 FILM NUMBER: 111206078 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001023024 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 582301143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 BARCLAY BLVD CITY: LINCOLNSHIRE STATE: IL ZIP: 60069 BUSINESS PHONE: 8474780500 MAIL ADDRESS: STREET 1: 111 BARCLAY BLVD CITY: LINCOLNSHIRE STATE: IL ZIP: 60069 FORMER COMPANY: FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC DATE OF NAME CHANGE: 19991027 4 1 primary_doc.xml PRIMARY DOCUMENT X0304 4 2011-11-14 0 0001023024 BIOSANTE PHARMACEUTICALS INC BPAX 0001241294 ROSENOW EDWARD C III C/O BIOSANTE PHARMACEUTICALS, INC. 111 BARCLAY BOULEVARD LINCOLNSHIRE IL 60069 1 0 0 0 Common Stock 2011-11-14 4 P 0 3000 2.37 A 20540 D /s/ Phillip B. Donenberg, attorney-in-fact 2011-11-15